Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Mimedx Group Inc (MDXG)  
$7.50 0.19 (2.6%) as of 4:30 Thu 5/2


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 111,035,000
Market Cap: 832.76(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.65 - $9.14
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 5.3
Insider 3/6 Months : 5.9
Guru Rank Number :  614
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   MiMedx Group is a wound care and a therapeutic biologics company, developing and distributing placental tissue allografts. Co. provides products in the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Co.'s biomaterial platform technologies include AmnioFix®, EpiFix®, EpiCord®, AmnioCord® and AmnioFill®. AmnioFix and EpiFix are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. EpiCord and AmnioCord are tissue allografts derived from umbilical cord tissue. AmnioFill is a placental connective tissue matrix, derived from the placental disc and other placental tissue.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 5,000 105,000 105,000
Total Buy Value $0 $35,787 $676,221 $676,221
Total People Bought 0 1 2 2
Total Buy Transactions 0 1 3 3
Total Shares Sold 82,188 82,188 172,426 499,684
Total Sell Value $659,218 $659,218 $1,153,656 $2,406,837
Total People Sold 2 2 5 9
Total Sell Transactions 5 5 13 38
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 328
  Page 2 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Carlson Peter M Chief Financial Officer   •       –      –    2023-05-10 4 S $5.93 $35,414 D/D (5,976) 656,435 -30%     
   Phelan William Lawrence Chief Accounting Officer   •       –      –    2023-05-10 4 S $5.93 $9,452 D/D (1,595) 184,219 -30%     
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2023-05-10 4 S $5.93 $34,780 D/D (5,869) 331,775 -30%     
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2023-05-04 4 S $5.34 $276,470 D/D (51,756) 337,644 -38%     
   Phelan William Lawrence Chief Accounting Officer   •       –      –    2023-05-02 4 S $3.80 $19,739 D/D (5,200) 185,814 -114%     
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2023-04-25 4 S $3.74 $22,415 D/D (5,987) 389,400 -110%     
   Carlson Peter M Chief Financial Officer   •       –      –    2023-04-25 4 S $3.74 $22,816 D/D (6,094) 662,411 -110%     
   Hulse William Frank Iv General Counsel and CAO   •       –      –    2023-04-25 4 S $3.74 $22,419 D/D (5,988) 462,434 -110%     
   Phelan William Lawrence Chief Accounting Officer   •       –      –    2023-04-25 4 S $3.74 $6,095 D/D (1,628) 191,014 -110%     
   Hulse William Frank Iv General Counsel and CAO   •       –      –    2023-04-11 4 S $3.31 $19,843 D/D (5,995) 468,422 -125%     
   Phelan William Lawrence Chief Accounting Officer   •       –      –    2023-04-11 4 S $3.31 $5,402 D/D (1,632) 192,642 -125%     
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2023-04-11 4 S $3.31 $19,847 D/D (5,996) 395,387 -125%     
   Carlson Peter M Chief Financial Officer   •       –      –    2023-04-11 4 S $3.31 $20,191 D/D (6,100) 668,505 -125%     
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2023-03-07 4 S $4.24 $52,442 D/D (12,355) 266,318 -81%     
   Hulse William Frank Iv General Counsel and CAO   •       –      –    2023-03-07 4 S $4.24 $47,998 D/D (11,308) 338,053 -81%     
   Phelan William Lawrence Chief Accounting Officer   •       –      –    2023-03-07 4 S $4.24 $14,415 D/D (3,396) 141,244 -81%     
   Carlson Peter M Chief Financial Officer   •       –      –    2023-03-07 4 S $4.24 $51,173 D/D (12,056) 534,150 -81%     
   Carlson Peter M Chief Financial Officer   •       –      –    2023-02-23 4 S $4.50 $85,416 D/D (19,000) 546,206 -43%     
   Hulse William Frank Iv General Counsel and CAO   •       –      –    2023-02-23 4 S $4.53 $70,477 D/D (15,555) 349,361 -43%     
   Carlson Peter M Chief Financial Officer   •       –      –    2022-12-22 4 S $2.82 $14,053 D/D (4,992) 565,206 -98%     
   Newton Todd Interim CEO   •       •      –    2022-09-15 4 A $0.00 $0 D/D 200,000 325,618     -
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2022-09-13 4 S $3.46 $28,785 D/D (8,329) 278,673 -3%     
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2022-09-12 4 S $3.44 $65,284 D/D (19,000) 287,002 -3%     
   Stein Robert Benjamin President, Regenerative Med.   •       –      –    2022-08-12 4 S $4.04 $34,344 D/D (8,503) 306,002 33%     
   Kashyap Rohit President, WC & Surgical   •       –      –    2022-08-09 4 S $4.21 $51,939 D/D (12,343) 430,072 36%     
  328 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us